Brueckmann, Martina <br/><br/>
Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure.  [electronic resource] 

 -  Thrombosis research  Mar 2003 
 - 259-63 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0049-3848 
<br/><br/><label>Standard No.: </label>10.1016/s0049-3848(03)00243-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Bacterial Agents<br/>Anticoagulants--pharmacology<br/>Combined Modality Therapy<br/>Disseminated Intravascular Coagulation--prevention & control<br/>Drainage<br/>Drug Evaluation<br/>Drug Therapy, Combination--therapeutic use<br/>Female<br/>Humans<br/>Knee Joint--surgery<br/>Multiple Organ Failure--blood<br/>Postoperative Complications--blood<br/>Protein C--pharmacology<br/>Recombinant Proteins--pharmacology<br/>Retropharyngeal Abscess--drug therapy<br/>Systemic Inflammatory Response Syndrome--complications<br/>Urinary Catheterization--adverse effects<br/>Urinary Tract Infections--complications